Filters

Pp-204 manufacturers

Filters

None products found

pp-204

Solution for infusion

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Indication: Celiac disease — antigen-specific immune tolerance induction for gluten sensitivity Clinical stage: Phase 2b Modality: Biological (antigen-coupled biodegradable PLGA nanoparticle — novel NBE/nanoparticle platform) Mechanism / Target: Gliadin peptide-coupled PLGA (poly lactic-co-glycolic acid) biodegradable nanoparticles; induces antigen-specific immune tolerance to gluten by targeting tolerogenic antigen-presenting cells (APCs) in spleen; reprograms T-cell response to gluten without systemic immunosuppression Route / form: IV infusion Differentiation: First-in-class antigen-specific tolerance induction therapy for celiac disease; only disease-modifying approach (vs. strict gluten-free diet as sole current option); FDA Fast Track Designation; no systemic immunosuppression;
Manufacturer #39341
Europe-based clinical-stage biotech developing Rx nanoparticle-based immune-tolerance therapies using a proprietary platform for antigen-specific tolerance. Injectable pipeline targets autoimmune diseases, allergies, and unwanted immune responses.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.